Clarification of LTE DESI Drugs and Oral Anti-Cancer Agents

Please see the attached memo from Cynthia Tudor, Ph.D., Director, Medicare Drug Benefit Group, regarding LTE DESI drugs and oral anti-cancer agents. Thank you.